WallStSmart

The Clorox Company (CLX)vsProcter & Gamble Company (PG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Procter & Gamble Company generates 1195% more annual revenue ($87.03B vs $6.72B). PG leads profitability with a 18.4% profit margin vs 8.7%. CLX appears more attractively valued with a PEG of 1.17. PG earns a higher WallStSmart Score of 55/100 (C).

CLX

Buy

53

out of 100

Grade: C-

Growth: 2.0Profit: 7.5Value: 4.7Quality: 3.3
Piotroski: 2/9

PG

Buy

55

out of 100

Grade: C

Growth: 3.3Profit: 8.5Value: 3.3Quality: 4.8
Piotroski: 4/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CLXSignificantly Overvalued (-24.4%)

Margin of Safety

-24.4%

Fair Value

$101.26

Current Price

$87.76

$13.50 premium

UndervaluedFair: $101.26Overvalued
PGSignificantly Overvalued (-44.5%)

Margin of Safety

-44.5%

Fair Value

$100.54

Current Price

$145.27

$44.73 premium

UndervaluedFair: $100.54Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CLX1 strengths · Avg: 10.0/10
Return on EquityProfitability
652.2%10/10

Every $100 of equity generates 652 in profit

PG4 strengths · Avg: 8.8/10
Market CapQuality
$337.41B10/10

Mega-cap, among the largest globally

Return on EquityProfitability
29.5%9/10

Every $100 of equity generates 30 in profit

Operating MarginProfitability
22.1%8/10

Strong operational efficiency at 22.1%

Free Cash FlowQuality
$4.87B8/10

Generating 4.9B in free cash flow

Areas to Watch

CLX4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Price/BookValuation
118.6x2/10

Trading at 118.6x book value

Revenue GrowthGrowth
-2.0%2/10

Revenue declined 2.0%

EPS GrowthGrowth
-50.1%2/10

Earnings declined 50.1%

PG3 concerns · Avg: 2.7/10
Revenue GrowthGrowth
1.5%4/10

1.5% revenue growth

PEG RatioValuation
3.662/10

Expensive relative to growth rate

EPS GrowthGrowth
-15.5%2/10

Earnings declined 15.5%

Comparative Analysis Report

WallStSmart Research

Bull Case : CLX

The strongest argument for CLX centers on Return on Equity. PEG of 1.17 suggests the stock is reasonably priced for its growth.

Bull Case : PG

The strongest argument for PG centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 18.4% and operating margin at 22.1%.

Bear Case : CLX

The primary concerns for CLX are Piotroski F-Score, Price/Book, Revenue Growth. Debt-to-equity of 61.33 is elevated, increasing financial risk.

Bear Case : PG

The primary concerns for PG are Revenue Growth, PEG Ratio, EPS Growth.

Key Dynamics to Monitor

CLX carries more volatility with a beta of 0.54 — expect wider price swings.

PG is growing revenue faster at 1.5% — sustainability is the question.

PG generates stronger free cash flow (4.9B), providing more financial flexibility.

Monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

PG scores higher overall (55/100 vs 53/100), backed by strong 18.4% margins. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

The Clorox Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

The Clorox Company, based in Oakland, California, is an American global manufacturer and marketer of consumer and professional products.

Procter & Gamble Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

The Procter & Gamble Company (P&G) is an American multinational consumer goods corporation headquartered in Cincinnati, Ohio, founded in 1837 by William Procter and James Gamble. It specializes in a wide range of personal health, consumer health, personal care, and hygiene products; these products are organized into several segments including Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine, & Family Care. Before the sale of Pringles to Kellogg's, its product portfolio also included food, snacks, and beverages.

Visit Website →

Want to dig deeper into these stocks?